Click for best price
Human Immunodeficiency Virus HIV Market Size, Share 2022
HIV (Human immunodeficiency virus) is a retrovirus which causes HIV infection and attacks the CD-4 cells (T-cells) in the immune system of human body. HIV reduces the number of T-cells in the body and makes the immune system vulnerable to life-threatening infections and cancers. An infected person cannot get rid of this virus properly but its effects can be reduced with the treatment.
This report contains market size and forecasts of Human Immunodeficiency Virus (HIV) in Global, including the following market information:
Global Human Immunodeficiency Virus (HIV) Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Human Immunodeficiency Virus (HIV) market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Diagnosis Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Human Immunodeficiency Virus (HIV) include Gilead, GlaxoSmithKline, Johnson & Johnson, Merck, AbbVie, Bristol-Myers Squibb, Boehringer Ingelheim, Genentech and Cipla. etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Human Immunodeficiency Virus (HIV) companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Human Immunodeficiency Virus (HIV) Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Human Immunodeficiency Virus (HIV) Market Segment Percentages, by Type, 2021 (%)
Diagnosis
Treatment
Global Human Immunodeficiency Virus (HIV) Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Human Immunodeficiency Virus (HIV) Market Segment Percentages, by Application, 2021 (%)
Hospitals
Ambulatory Surgical Centers
Diagnostic Centers
Homecare Settings
Others
Global Human Immunodeficiency Virus (HIV) Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Human Immunodeficiency Virus (HIV) Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Human Immunodeficiency Virus (HIV) revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Human Immunodeficiency Virus (HIV) revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Gilead
GlaxoSmithKline
Johnson & Johnson
Merck
AbbVie
Bristol-Myers Squibb
Boehringer Ingelheim
Genentech
Cipla
| Report Attributes |
Report Details |
| Report Title |
Human Immunodeficiency Virus (HIV) Market, Global Outlook and Forecast 2022-2028 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2021 |
| Forecast Year |
2029 |
| Number of Pages |
68 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Human Immunodeficiency Virus (HIV) Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Human Immunodeficiency Virus (HIV) Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Human Immunodeficiency Virus (HIV) Overall Market Size
2.1 Global Human Immunodeficiency Virus (HIV) Market Size: 2021 VS 2028
2.2 Global Human Immunodeficiency Virus (HIV) Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Human Immunodeficiency Virus (HIV) Players in Global Market
3.2 Top Global Human Immunodeficiency Virus (HIV) Companies Ranked by Revenue
3.3 Global Human Immunodeficiency Virus (HIV) Revenue by Companies
3.4 Top 3 and Top 5 Human Immunodeficiency Virus (HIV) Companies in Global Market, by Revenue in 2021
3.5 Global Companies Human Immunodeficiency Virus (HIV) Product Type
3.6 Tier 1, Tier 2 and Tier 3 Human Immunodeficiency Virus (HIV) Players in Global Market
3.6.1 List of Global Tier 1 Human Immunodeficiency Virus (HIV) Companies
3.6.2 List of Global Tier 2 and Tier 3 Human Immunodeficiency Virus (HIV) Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Human Immunodeficiency Virus (HIV) Market Size Markets, 2021 & 2028
4.1.2 Diagnosis
4.1.3 Treatment
4.2 By Type - Global Human Immunodeficiency Virus (HIV) Revenue & Forecasts
4.2.1 By Type - Global Human Immunodeficiency Virus (HIV) Revenue, 2017-2022
4.2.2 By Type - Global Human Immunodeficiency Virus (HIV) Revenue, 2023-2028
4.2.3 By Type - Global Human Immunodeficiency Virus (HIV) Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Human Immunodeficiency Virus (HIV) Market Size, 2021 & 2028
5.1.2 Hospitals
5.1.3 Ambulatory Surgical Centers
5.1.4 Diagnostic Centers
5.1.5 Homecare Settings
5.1.6 Others
5.2 By Application - Global Human Immunodeficiency Virus (HIV) Revenue & Forecasts
5.2.1 By Application - Global Human Immunodeficiency Virus (HIV) Revenue, 2017-2022
5.2.2 By Application - Global Human Immunodeficiency Virus (HIV) Revenue, 2023-2028
5.2.3 By Application - Global Human Immunodeficiency Virus (HIV) Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Human Immunodeficiency Virus (HIV) Market Size, 2021 & 2028
6.2 By Region - Global Human Immunodeficiency Virus (HIV) Revenue & Forecasts
6.2.1 By Region - Global Human Immunodeficiency Virus (HIV) Revenue, 2017-2022
6.2.2 By Region - Global Human Immunodeficiency Virus (HIV) Revenue, 2023-2028
6.2.3 By Region - Global Human Immunodeficiency Virus (HIV) Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Human Immunodeficiency Virus (HIV) Revenue, 2017-2028
6.3.2 US Human Immunodeficiency Virus (HIV) Market Size, 2017-2028
6.3.3 Canada Human Immunodeficiency Virus (HIV) Market Size, 2017-2028
6.3.4 Mexico Human Immunodeficiency Virus (HIV) Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Human Immunodeficiency Virus (HIV) Revenue, 2017-2028
6.4.2 Germany Human Immunodeficiency Virus (HIV) Market Size, 2017-2028
6.4.3 France Human Immunodeficiency Virus (HIV) Market Size, 2017-2028
6.4.4 U.K. Human Immunodeficiency Virus (HIV) Market Size, 2017-2028
6.4.5 Italy Human Immunodeficiency Virus (HIV) Market Size, 2017-2028
6.4.6 Russia Human Immunodeficiency Virus (HIV) Market Size, 2017-2028
6.4.7 Nordic Countries Human Immunodeficiency Virus (HIV) Market Size, 2017-2028
6.4.8 Benelux Human Immunodeficiency Virus (HIV) Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Human Immunodeficiency Virus (HIV) Revenue, 2017-2028
6.5.2 China Human Immunodeficiency Virus (HIV) Market Size, 2017-2028
6.5.3 Japan Human Immunodeficiency Virus (HIV) Market Size, 2017-2028
6.5.4 South Korea Human Immunodeficiency Virus (HIV) Market Size, 2017-2028
6.5.5 Southeast Asia Human Immunodeficiency Virus (HIV) Market Size, 2017-2028
6.5.6 India Human Immunodeficiency Virus (HIV) Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Human Immunodeficiency Virus (HIV) Revenue, 2017-2028
6.6.2 Brazil Human Immunodeficiency Virus (HIV) Market Size, 2017-2028
6.6.3 Argentina Human Immunodeficiency Virus (HIV) Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Human Immunodeficiency Virus (HIV) Revenue, 2017-2028
6.7.2 Turkey Human Immunodeficiency Virus (HIV) Market Size, 2017-2028
6.7.3 Israel Human Immunodeficiency Virus (HIV) Market Size, 2017-2028
6.7.4 Saudi Arabia Human Immunodeficiency Virus (HIV) Market Size, 2017-2028
6.7.5 UAE Human Immunodeficiency Virus (HIV) Market Size, 2017-2028
7 Players Profiles
7.1 Gilead
7.1.1 Gilead Corporate Summary
7.1.2 Gilead Business Overview
7.1.3 Gilead Human Immunodeficiency Virus (HIV) Major Product Offerings
7.1.4 Gilead Human Immunodeficiency Virus (HIV) Revenue in Global Market (2017-2022)
7.1.5 Gilead Key News
7.2 GlaxoSmithKline
7.2.1 GlaxoSmithKline Corporate Summary
7.2.2 GlaxoSmithKline Business Overview
7.2.3 GlaxoSmithKline Human Immunodeficiency Virus (HIV) Major Product Offerings
7.2.4 GlaxoSmithKline Human Immunodeficiency Virus (HIV) Revenue in Global Market (2017-2022)
7.2.5 GlaxoSmithKline Key News
7.3 Johnson & Johnson
7.3.1 Johnson & Johnson Corporate Summary
7.3.2 Johnson & Johnson Business Overview
7.3.3 Johnson & Johnson Human Immunodeficiency Virus (HIV) Major Product Offerings
7.3.4 Johnson & Johnson Human Immunodeficiency Virus (HIV) Revenue in Global Market (2017-2022)
7.3.5 Johnson & Johnson Key News
7.4 Merck
7.4.1 Merck Corporate Summary
7.4.2 Merck Business Overview
7.4.3 Merck Human Immunodeficiency Virus (HIV) Major Product Offerings
7.4.4 Merck Human Immunodeficiency Virus (HIV) Revenue in Global Market (2017-2022)
7.4.5 Merck Key News
7.5 AbbVie
7.5.1 AbbVie Corporate Summary
7.5.2 AbbVie Business Overview
7.5.3 AbbVie Human Immunodeficiency Virus (HIV) Major Product Offerings
7.5.4 AbbVie Human Immunodeficiency Virus (HIV) Revenue in Global Market (2017-2022)
7.5.5 AbbVie Key News
7.6 Bristol-Myers Squibb
7.6.1 Bristol-Myers Squibb Corporate Summary
7.6.2 Bristol-Myers Squibb Business Overview
7.6.3 Bristol-Myers Squibb Human Immunodeficiency Virus (HIV) Major Product Offerings
7.6.4 Bristol-Myers Squibb Human Immunodeficiency Virus (HIV) Revenue in Global Market (2017-2022)
7.6.5 Bristol-Myers Squibb Key News
7.7 Boehringer Ingelheim
7.7.1 Boehringer Ingelheim Corporate Summary
7.7.2 Boehringer Ingelheim Business Overview
7.7.3 Boehringer Ingelheim Human Immunodeficiency Virus (HIV) Major Product Offerings
7.7.4 Boehringer Ingelheim Human Immunodeficiency Virus (HIV) Revenue in Global Market (2017-2022)
7.7.5 Boehringer Ingelheim Key News
7.8 Genentech
7.8.1 Genentech Corporate Summary
7.8.2 Genentech Business Overview
7.8.3 Genentech Human Immunodeficiency Virus (HIV) Major Product Offerings
7.8.4 Genentech Human Immunodeficiency Virus (HIV) Revenue in Global Market (2017-2022)
7.8.5 Genentech Key News
7.9 Cipla
7.9.1 Cipla Corporate Summary
7.9.2 Cipla Business Overview
7.9.3 Cipla Human Immunodeficiency Virus (HIV) Major Product Offerings
7.9.4 Cipla Human Immunodeficiency Virus (HIV) Revenue in Global Market (2017-2022)
7.9.5 Cipla Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Human Immunodeficiency Virus (HIV) Market Opportunities & Trends in Global Market
Table 2. Human Immunodeficiency Virus (HIV) Market Drivers in Global Market
Table 3. Human Immunodeficiency Virus (HIV) Market Restraints in Global Market
Table 4. Key Players of Human Immunodeficiency Virus (HIV) in Global Market
Table 5. Top Human Immunodeficiency Virus (HIV) Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Human Immunodeficiency Virus (HIV) Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Human Immunodeficiency Virus (HIV) Revenue Share by Companies, 2017-2022
Table 8. Global Companies Human Immunodeficiency Virus (HIV) Product Type
Table 9. List of Global Tier 1 Human Immunodeficiency Virus (HIV) Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Human Immunodeficiency Virus (HIV) Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type ? Global Human Immunodeficiency Virus (HIV) Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Human Immunodeficiency Virus (HIV) Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Human Immunodeficiency Virus (HIV) Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application ? Global Human Immunodeficiency Virus (HIV) Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Human Immunodeficiency Virus (HIV) Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Human Immunodeficiency Virus (HIV) Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region ? Global Human Immunodeficiency Virus (HIV) Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Human Immunodeficiency Virus (HIV) Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Human Immunodeficiency Virus (HIV) Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Human Immunodeficiency Virus (HIV) Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Human Immunodeficiency Virus (HIV) Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Human Immunodeficiency Virus (HIV) Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Human Immunodeficiency Virus (HIV) Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Human Immunodeficiency Virus (HIV) Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Human Immunodeficiency Virus (HIV) Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Human Immunodeficiency Virus (HIV) Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Human Immunodeficiency Virus (HIV) Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Human Immunodeficiency Virus (HIV) Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Human Immunodeficiency Virus (HIV) Revenue, (US$, Mn), 2023-2028
Table 30. Gilead Corporate Summary
Table 31. Gilead Human Immunodeficiency Virus (HIV) Product Offerings
Table 32. Gilead Human Immunodeficiency Virus (HIV) Revenue (US$, Mn), (2017-2022)
Table 33. GlaxoSmithKline Corporate Summary
Table 34. GlaxoSmithKline Human Immunodeficiency Virus (HIV) Product Offerings
Table 35. GlaxoSmithKline Human Immunodeficiency Virus (HIV) Revenue (US$, Mn), (2017-2022)
Table 36. Johnson & Johnson Corporate Summary
Table 37. Johnson & Johnson Human Immunodeficiency Virus (HIV) Product Offerings
Table 38. Johnson & Johnson Human Immunodeficiency Virus (HIV) Revenue (US$, Mn), (2017-2022)
Table 39. Merck Corporate Summary
Table 40. Merck Human Immunodeficiency Virus (HIV) Product Offerings
Table 41. Merck Human Immunodeficiency Virus (HIV) Revenue (US$, Mn), (2017-2022)
Table 42. AbbVie Corporate Summary
Table 43. AbbVie Human Immunodeficiency Virus (HIV) Product Offerings
Table 44. AbbVie Human Immunodeficiency Virus (HIV) Revenue (US$, Mn), (2017-2022)
Table 45. Bristol-Myers Squibb Corporate Summary
Table 46. Bristol-Myers Squibb Human Immunodeficiency Virus (HIV) Product Offerings
Table 47. Bristol-Myers Squibb Human Immunodeficiency Virus (HIV) Revenue (US$, Mn), (2017-2022)
Table 48. Boehringer Ingelheim Corporate Summary
Table 49. Boehringer Ingelheim Human Immunodeficiency Virus (HIV) Product Offerings
Table 50. Boehringer Ingelheim Human Immunodeficiency Virus (HIV) Revenue (US$, Mn), (2017-2022)
Table 51. Genentech Corporate Summary
Table 52. Genentech Human Immunodeficiency Virus (HIV) Product Offerings
Table 53. Genentech Human Immunodeficiency Virus (HIV) Revenue (US$, Mn), (2017-2022)
Table 54. Cipla Corporate Summary
Table 55. Cipla Human Immunodeficiency Virus (HIV) Product Offerings
Table 56. Cipla Human Immunodeficiency Virus (HIV) Revenue (US$, Mn), (2017-2022)
List of Figures
Figure 1. Human Immunodeficiency Virus (HIV) Segment by Type in 2021
Figure 2. Human Immunodeficiency Virus (HIV) Segment by Application in 2021
Figure 3. Global Human Immunodeficiency Virus (HIV) Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Human Immunodeficiency Virus (HIV) Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Human Immunodeficiency Virus (HIV) Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Human Immunodeficiency Virus (HIV) Revenue in 2021
Figure 8. By Type - Global Human Immunodeficiency Virus (HIV) Revenue Market Share, 2017-2028
Figure 9. By Application - Global Human Immunodeficiency Virus (HIV) Revenue Market Share, 2017-2028
Figure 10. By Region - Global Human Immunodeficiency Virus (HIV) Revenue Market Share, 2017-2028
Figure 11. By Country - North America Human Immunodeficiency Virus (HIV) Revenue Market Share, 2017-2028
Figure 12. US Human Immunodeficiency Virus (HIV) Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Human Immunodeficiency Virus (HIV) Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Human Immunodeficiency Virus (HIV) Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Human Immunodeficiency Virus (HIV) Revenue Market Share, 2017-2028
Figure 16. Germany Human Immunodeficiency Virus (HIV) Revenue, (US$, Mn), 2017-2028
Figure 17. France Human Immunodeficiency Virus (HIV) Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Human Immunodeficiency Virus (HIV) Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Human Immunodeficiency Virus (HIV) Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Human Immunodeficiency Virus (HIV) Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Human Immunodeficiency Virus (HIV) Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Human Immunodeficiency Virus (HIV) Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Human Immunodeficiency Virus (HIV) Revenue Market Share, 2017-2028
Figure 24. China Human Immunodeficiency Virus (HIV) Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Human Immunodeficiency Virus (HIV) Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Human Immunodeficiency Virus (HIV) Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Human Immunodeficiency Virus (HIV) Revenue, (US$, Mn), 2017-2028
Figure 28. India Human Immunodeficiency Virus (HIV) Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Human Immunodeficiency Virus (HIV) Revenue Market Share, 2017-2028
Figure 30. Brazil Human Immunodeficiency Virus (HIV) Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Human Immunodeficiency Virus (HIV) Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Human Immunodeficiency Virus (HIV) Revenue Market Share, 2017-2028
Figure 33. Turkey Human Immunodeficiency Virus (HIV) Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Human Immunodeficiency Virus (HIV) Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Human Immunodeficiency Virus (HIV) Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Human Immunodeficiency Virus (HIV) Revenue, (US$, Mn), 2017-2028
Figure 37. Gilead Human Immunodeficiency Virus (HIV) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. GlaxoSmithKline Human Immunodeficiency Virus (HIV) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Johnson & Johnson Human Immunodeficiency Virus (HIV) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Merck Human Immunodeficiency Virus (HIV) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. AbbVie Human Immunodeficiency Virus (HIV) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Bristol-Myers Squibb Human Immunodeficiency Virus (HIV) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Boehringer Ingelheim Human Immunodeficiency Virus (HIV) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Genentech Human Immunodeficiency Virus (HIV) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Cipla Human Immunodeficiency Virus (HIV) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
